Avid Bioservices Inc (CDMO)

[aikifredicist]

Thanks for your comment FTM. I realize that PD-1 may be used with chemo agents in the near term but the vector of investigation is away from their continued use without being sent special delivery on a MAB themselves.

Mix two novel chemicals together in a patient and what do you get ? Not necessarily an additive effect. Could be multiplicative with a multiplier <1. Could be disaster. We have to await the clinical results and not assume that everything is necessarily going to work to our advantage.

Nonetheless, I'm maintaining my 110K stock investment in PPHM.